TI response by baseline FAB type, IPSS risk category, cytogenetic findings, and transfusion burden
| Characteristic . | No. . | Patients with TI response, no. (%) . |
|---|---|---|
| FAB type | ||
| RA | 47 | 16 (34) |
| RARS | 86 | 30 (35) |
| RAEB | 24 | 6 (25) |
| CMML | 20 | 3 (15) |
| RAEB-t | 5 | 0 |
| AML | 1 | 0 |
| Missing | 31 | 1 (3) |
| IPSS risk category | ||
| Low | 92 | 31 (34) |
| Intermediate-1 | 76 | 23 (30) |
| Intermediate-2/high | 8 | 0 |
| Missing | 38 | 2 (5) |
| Cytogenetic findings | ||
| Normal karyotype | 160 | 42 (26) |
| Abnormal karyotype | 47 | 13 (28) |
| Missing | 7 | 1 (14) |
| Transfusion burden per 8 wk | ||
| Fewer than 4 units pRBC | 75 | 33 (44) |
| Four or more units pRBC | 139 | 23 (17) |
| Characteristic . | No. . | Patients with TI response, no. (%) . |
|---|---|---|
| FAB type | ||
| RA | 47 | 16 (34) |
| RARS | 86 | 30 (35) |
| RAEB | 24 | 6 (25) |
| CMML | 20 | 3 (15) |
| RAEB-t | 5 | 0 |
| AML | 1 | 0 |
| Missing | 31 | 1 (3) |
| IPSS risk category | ||
| Low | 92 | 31 (34) |
| Intermediate-1 | 76 | 23 (30) |
| Intermediate-2/high | 8 | 0 |
| Missing | 38 | 2 (5) |
| Cytogenetic findings | ||
| Normal karyotype | 160 | 42 (26) |
| Abnormal karyotype | 47 | 13 (28) |
| Missing | 7 | 1 (14) |
| Transfusion burden per 8 wk | ||
| Fewer than 4 units pRBC | 75 | 33 (44) |
| Four or more units pRBC | 139 | 23 (17) |
pRBC indicates packed RBCs.